Yıl: 2005 Cilt: 31 Sayı: 1 Sayfa Aralığı: 71 - 74 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Diabet ve akciğer

Öz:
Diabetes Mellitus, toplumda en sık görülen kronik, metabolik hastalıktır. Dünyada yaklaşık 120 milyon diabetli hasta bulunmaktadır. Ülkemizde diabet insidansı %1,6-2, prevelansı ise %3,5-5 olarak bildirilmiştir. Diabetin diğer organ komplikasyonlarının yanı sıra akciğerler üzerine de olumsuz etkileri vardır. Diabetli hastalarda en sık görülen pulmoner komplikasyon enfeksiyonlardır. Ayrıca solunum fonksiyonlarında anormallikler ve uyku apne sendromu da görülebilir.
Anahtar Kelime: Diabetes mellitus Akciğer

Konular: Cerrahi

Diabetes mellitus and lung

Öz:
Diabetes mellitus is the most prevelant chronic endocrine disease in the community. There is nearly 120 million people with diabetes mellitus worldwide. In our country, the incidence and the prevelance of diabetes mellitus has been reported to be 1,6-2% and 3,5-5 % respectively. Like many complications observed in almost every organ-system, diabetes has some harmful effects on lungs. The most common pulmonary complication observed in diabetic patients is pulmonary infection. In addition to pulmonary infections, diabetes may also cause pulmonary function abnormalities and sleep apne syndrome.
Anahtar Kelime: Diabetes Mellitus Lung

Konular: Cerrahi
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1. Bennet PH. Classificationand Diagnosis of Diabetes Mellitus. In: Pickup J, Williams G (eds). Textbook of Diabetes. London: Blackwell Scientific Publications; 1991. 37-44. 2. Şengöz G. Diabetes mellitus ve enfeksiyon hastalıkları. In: Yenigün M (ed). Her Yönüyle Diabetes Mellitus. İstanbul: Nobel Tıp Kitapevi; 2001. 533-43. 3. Nazlıcan Ö, Alan S. Diabetes mellitusta enfeksiyon immunolojisi. In: Yenigün M (ed). Her Yönüyle Diabetes Mellitus. İstanbul: Nobel Tıp Kitabevi; 2001. 569-77. 4. Marhoffer W, Stain M, Maeser E, Federlin K. Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care 1992;15:256-60. 5. Debczynski W, Pietruska Z. Chemotaxis and spontaneus migration of neutrophil leukocytes from patients with diabetes. Pol Tyg Lek 1994; 49:11-3. 6. Marfoffer W Stein M, Schleinkofer L, Federlin K. Monitoring of polymorphonuclear leukocyte functions in diabetes mellitus. A comparative study of conventional radiometric function tests and low-light imaging systems. J Biolumin Chemilumin 1994;9:165-70. 7. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B. Impaired leucocyte functions in diabetic patients. Diabet Med 1997;14:29-34. 8. Senior PA, Marshall SM, Thomas TH. Dysregulation of PMN antigen expression in Type 2 diabetes may reflect a generalized defect of exocytosis: influence of hypertension and microalbuminuria. J Leukoc Biol 1999; 65: 800-7. 9. McManus LM, Bloodworth RC, Prihoda TJ, Blodgett JL, Pinckard RN. Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia. J Leukoc Biol 2001;70:395-404. 10. Alfonso C, Han JO, Williams GS, Karlsson L. The impact of H2-DM on humoral immune responses. J Immunol 2001;167:6348-55.
  • 11. Michalkova D, Mikulecky M, Tibenska E. Alterations in lymphocyte subpopulations in peripheral blood at manifestation of type 1 diabetes mellitus in childhood. Bratisl Lek Listy 2000; 101: 365-70. 12. Kukreja A, Cost G Marker J, Zhang C, Sun Z, Lin-Su K, Ten S, et all. Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 2002;109:131-40. 13. Matthay MA. The Lungs and Endocrine Disease. In: Murray JF, Nadel JA. Textbook of Respiratory Medicine. Philadelphia: W.B. Saunders Company; 1994;2463-74. 14. Koziel H, Koziel MJ. Pulmonary complications of diabetes mellitus. Pneumonia. Infect Dis Clin North Am 1995;9:65-96. 15. Erişkin ve Çocuklarda Toplum Kökenli Pnömoniler ve Akut Bronşiolit Tanı Ve Tedavi Rehberi. Toraks Dergisi Cilt 3, Ek 3, 2002. 16. Wang Ch, Yu CT, Lin HC, Liu CY, Kuo HP. Hypodense alveolar macrophages in patients with diabetes mellitus and active pulmonary tuberculosis. Tuber Lung Dis 1999; 79: 235- 42. 17. Bacakoglu F, Basoglu OK, Cok G, Sayiner A, Ates M. Pulmonary tuberculosis in patients with diabetes mellitus. Respiration 2001; 68: 595-600. 18. Morris JT, Seaworth BJ, McAllister CK. Pulmonary tuberculosis in diabetics. Chest 1992;102:539-41. 19. Bashar M, Alcabes P, Rom WN, Condos R. Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987 to 1997. Chest 2001;120:1435-7. 20. Nicolaie T, Zavoianu C, Nuta P. Pulmonary involvement in diabetes mellitus. Rom J Intern Med. 2003;41:365-74. 21. Hsia CC, Raskin P. The diabetic lung: relevance of alveolar microangiopathy for the use of inhaled insulin. Am J Med 2005;118:205-11. 22. Dalquen P. The lung in diabetes mellitus. Respiration 1999;66:12-3. 23. Weynand B, Jonckheere A, Frans A, Rahier J. Diabetes mellitus induces a thickening of the pulmonary basal lamina. Respiration 1999; 66: 14-9. 24. Scano G, Filippelli M, Romagnoli I, Mancini M, Misuri G, Duranti R, Rosi E. Hypoxic and hypercapnic breathlessness in patients with type 1 diabetes mellitus. Chest 2000;117:960-7. 25. Mancini M, Filippelli M, Seghieri G, Iandelli I, Innocenti F, Duranti R,Scano G. Respiratory muscle function and hypoxic ventilatory control in patients with type 1 diabetes. Chest 1999;115:1553-62. 26. Ljubic S, Metelko Z, Car N, Roglic G, Drazic Z. Reduction of diffusion capacity for carbon monoxide in diabetic patients. Chest 1998;114:1033-5. 27. Cazzato S, Bernardi F, Salardi S, Tassinari D, Corsini I, Ragni L, Cicognani A, Cacciari E. Lung function in children with diabetes mellitus. Pediatr Pulmonol 2004; 37:17-23. 28. Boulbou MS, Gourgoulianis KI, Klisiaris VK, Tsikrikas TS, Stathakis NE, Molyvdas PA. Diabetes mellitus and lung function. Med Princ Pract 2003;12:87-91. 29. Bottini P, Scionti L, Santeusanio F, Casucci G, Tantucci C. Impairment of the respiratory system in diabetic autonomic neuropathy. Diabetes Nutr Metab 2000;13:165-72. 30. Cavalher-Machado SC, de Lima WT, Damazo AS, de Frias Carvalho V, Martins MA, e Silva PM, Sannomiya P. Downregulation of mast cell activation and airway reactivity in diabetic rats: role of insulin. Eur Respir J 2004;24:552-8. 31. Bottini P, Tantucci C. Sleep apnea syndrome in endocrine diseases. Respiration. 2003; 70:320-7 32. Royle P, Waugh N, McAuley L, McIntyre L, Thomas S. Inhaled insulin in diabetes mellitus. Cochrane Database Syst Rev 2004;3:CD003890.
APA ERDOĞAN B, Uzaslan E (2005). Diabet ve akciğer. , 71 - 74.
Chicago ERDOĞAN Bahadır Beril,Uzaslan Esra Diabet ve akciğer. (2005): 71 - 74.
MLA ERDOĞAN Bahadır Beril,Uzaslan Esra Diabet ve akciğer. , 2005, ss.71 - 74.
AMA ERDOĞAN B,Uzaslan E Diabet ve akciğer. . 2005; 71 - 74.
Vancouver ERDOĞAN B,Uzaslan E Diabet ve akciğer. . 2005; 71 - 74.
IEEE ERDOĞAN B,Uzaslan E "Diabet ve akciğer." , ss.71 - 74, 2005.
ISNAD ERDOĞAN, Bahadır Beril - Uzaslan, Esra. "Diabet ve akciğer". (2005), 71-74.
APA ERDOĞAN B, Uzaslan E (2005). Diabet ve akciğer. Uludağ Üniversitesi Tıp Fakültesi Dergisi, 31(1), 71 - 74.
Chicago ERDOĞAN Bahadır Beril,Uzaslan Esra Diabet ve akciğer. Uludağ Üniversitesi Tıp Fakültesi Dergisi 31, no.1 (2005): 71 - 74.
MLA ERDOĞAN Bahadır Beril,Uzaslan Esra Diabet ve akciğer. Uludağ Üniversitesi Tıp Fakültesi Dergisi, vol.31, no.1, 2005, ss.71 - 74.
AMA ERDOĞAN B,Uzaslan E Diabet ve akciğer. Uludağ Üniversitesi Tıp Fakültesi Dergisi. 2005; 31(1): 71 - 74.
Vancouver ERDOĞAN B,Uzaslan E Diabet ve akciğer. Uludağ Üniversitesi Tıp Fakültesi Dergisi. 2005; 31(1): 71 - 74.
IEEE ERDOĞAN B,Uzaslan E "Diabet ve akciğer." Uludağ Üniversitesi Tıp Fakültesi Dergisi, 31, ss.71 - 74, 2005.
ISNAD ERDOĞAN, Bahadır Beril - Uzaslan, Esra. "Diabet ve akciğer". Uludağ Üniversitesi Tıp Fakültesi Dergisi 31/1 (2005), 71-74.